Irhythm Technologies Inc (NASDAQ:IRTC) Director Vijay K. Lathi sold 57,430 shares of Irhythm Technologies stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $52.41, for a total value of $3,009,906.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Vijay K. Lathi also recently made the following trade(s):

  • On Thursday, December 7th, Vijay K. Lathi sold 150,000 shares of Irhythm Technologies stock. The shares were sold at an average price of $52.57, for a total value of $7,885,500.00.

Irhythm Technologies Inc (IRTC) traded up $0.80 during trading on Thursday, hitting $52.76. The company had a trading volume of 272,352 shares, compared to its average volume of 262,968. The company has a current ratio of 7.65, a quick ratio of 7.57 and a debt-to-equity ratio of 0.38. Irhythm Technologies Inc has a 12-month low of $24.25 and a 12-month high of $57.90.

Irhythm Technologies (NASDAQ:IRTC) last posted its quarterly earnings results on Wednesday, November 1st. The company reported ($0.29) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.34) by $0.05. Irhythm Technologies had a negative return on equity of 27.67% and a negative net margin of 27.56%. The firm had revenue of $25.04 million for the quarter, compared to the consensus estimate of $24.30 million. During the same period in the previous year, the business earned ($2.80) earnings per share. The company’s revenue for the quarter was up 49.2% compared to the same quarter last year. equities analysts anticipate that Irhythm Technologies Inc will post -1.17 earnings per share for the current fiscal year.

Several brokerages have weighed in on IRTC. Zacks Investment Research downgraded Irhythm Technologies from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Canaccord Genuity lifted their price target on Irhythm Technologies from $55.00 to $59.00 and gave the company a “buy” rating in a research note on Thursday, November 2nd. ValuEngine upgraded Irhythm Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, October 21st. Royal Bank Of Canada initiated coverage on Irhythm Technologies in a research note on Monday. They issued an “outperform” rating and a $79.00 price target on the stock. Finally, Dougherty & Co initiated coverage on Irhythm Technologies in a research note on Friday, December 1st. They issued a “neutral” rating on the stock. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $65.25.

Institutional investors have recently bought and sold shares of the stock. Advisor Group Inc. raised its holdings in Irhythm Technologies by 763.9% during the third quarter. Advisor Group Inc. now owns 2,920 shares of the company’s stock worth $151,000 after purchasing an additional 2,582 shares during the last quarter. Legal & General Group Plc raised its holdings in Irhythm Technologies by 131.0% during the second quarter. Legal & General Group Plc now owns 3,373 shares of the company’s stock worth $143,000 after purchasing an additional 1,913 shares during the last quarter. First Mercantile Trust Co. acquired a new position in Irhythm Technologies during the second quarter worth $221,000. Voya Investment Management LLC acquired a new position in Irhythm Technologies during the second quarter worth $274,000. Finally, GSA Capital Partners LLP acquired a new position in Irhythm Technologies during the second quarter worth $289,000. Hedge funds and other institutional investors own 97.80% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/12/07/vijay-k-lathi-sells-57430-shares-of-irhythm-technologies-inc-irtc-stock.html.

About Irhythm Technologies

iRhythm Technologies, Inc is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report.

Insider Buying and Selling by Quarter for Irhythm Technologies (NASDAQ:IRTC)

Receive News & Ratings for Irhythm Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.